Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
DNA Script, a start-up based in Paris, has won $2.7 million in grants from Bpifrance, a state-backed program for French entrepreneurs. The company uses enzymes, rather than chemical processes, to assemble synthetic DNA for use in cell therapies and gene editing. It claims that its process makes longer DNA constructs more quickly and cleanly than competing approaches do. DNA Script raised $13 million in September 2017 from investors, including the venture arms of Illumina and Merck KGaA.
This article has been sent to the following recipient: